RecruitingNot ApplicableNCT06563206

Exergame and Robotic Therapy Impact on Tenascin-C and Functional Outcome on Stroke Patients

Comparison of Tenascin-C Value Rates and Functional Outcomes Between Exergame Therapy and Robotic Therapy in Post-Stroke Patients


Sponsor

Hasanuddin University

Enrollment

48 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are: 1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Conventional, a procedure called Exergame, and others for people with paralysis arm and stroke. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREExergame

Hand Training assisted with Virtual-Reality

PROCEDURERobotic

Hand Training assisted with Robotic Syrebo

PROCEDUREConventional

Hand Training with Physical Therapist


Locations(2)

Hasanuddin University, Faculty of Medicine

Makassar, South Sulawesi, Indonesia

Wahidin Sudirohusodo General Hospital

Makassar, South Sulawesi, Indonesia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06563206


Related Trials